Phages as biospecific probes

Immunoassay and Other Bioanalytical Techniques

Volumn , Issue , 2016, Pages 187-216

  Petrenko, Valery A ^a   Brigati, Jennifer R ^b  

^a AUBURN UNIVERSITY   (United States)

^b MARYVILLE COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85131612424     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (179)

1. Hammerschmidt, S., Hacker, J., and Klenk, H. D., Threat of infection: Microbes of high pathogenic potential-strategies for detection, control and eradication, Int. J. Med. Microbiol., 295 (3), 141-151, 2005.
2. Dennis, D. T., Inglesby, T. V., Henderson, D. A., Bartlett, J. G., Ascher, M. S., Eitzen, E., Fine, A. D., et al., Tularemia as a biological weapon: Medical and public health management, JAMA, 285 (21), 2763-2773, 2001.
3. Henderson, D. A., Inglesby, T. V., Bartlett, J. G., Ascher, M. S., Eitzen, E., Jahrling, P. B., Hauer, J., et al., Smallpox as a biological weapon: Medical and public health management, JAMA, 281 (22), 2127-2137, 1999.
4. Inglesby, T. V., Dennis, D. T., Henderson, D. A., Bartlett, J. G., Ascher, M. S., Eitzen, E., Fine, A. D., et al., Plague as a biological weapon: Medical and public health management, JAMA, 283 (17), 2281-2290, 2000.
5. Inglesby, T. V., Henderson, D. A., Bartlett, J. G., Ascher, M. S., Eitzen, E., Friedlander, A. M., Hauer, J., et al., Anthrax as a biological weapon: Medical and public health management, JAMA, 281 (18), 1735-1745, 1999.
6. Arnon, S. S., Schechter, R., Inglesby, T. V., Henderson, D. A., Bartlett, J. G., Ascher, M. S., Eitzen, E., et al., Botulinum toxin as a biological weapon: Medical and public health management, JAMA, 285 (8), 1059-1070, 2001.
7. Deisingh, A. K. and Thompson, M., Detection of infectious and toxigenic bacteria, Analyst., 127 (5), 567-581, 2002.
8. Smith, G. P. and Petrenko, V. A., Phage display, Chem. Rev., 97 (2), 391-410, 1997.
9. Petrenko, V. A. and Vodyanoy, V. J., Phage display for detection of biological threat agents, J. Microbiol. Methods., 53 (2), 253-262, 2003.
10. Petrenko, V. A. and Sorokulova, I. B., Detection of biological threats. A challenge for directed molecular evolution, J. Microbiol. Methods, 58 (2), 147-168, 2004.
11. Luppa, P. B., Sokoll, L. J., and Chan, D. W., Immunosensors-principles and applications to clinical chemistry [Review], Clin. Chim. Acta., 314 (1-2), 1-26, 2001.
12. Ziegler, C. and Gopel, W., Biosensor development, Curr. Opin. Chem. Biol., 2 (5), 585-591, 1998.
13. Naimushin, A. N., Spinelli, C. B., Soelberg, S. D., Mann, T., Stevens, R. C., Chinowsky, T., Kauffman, P., Yee, S., and Furlong, C. E., Airborne analyte detection with an aircraft-adapted surface plasmon resonance sensor system, Sens. Actuators B-Chem., 104 (2), 237-248, 2005.
14. Pancrazio, J. J., Whelan, J. P., Borkholder, D. A., Ma, W., and Stenger, D. A., Development and application of cell-based biosensors, Ann. Biomed. Eng., 27 (6), 697-711, 1999.
15. Shone, C., Wilton-Smith, P., Appleton, N., Hambleton, P., Modi, N., Gatley, S., and Melling, J., Monoclonal antibody-based immunoassay for type A Clostridium botulinum toxin is comparable to the mouse bioassay, Appl. Environ. Microbiol., 50 (1), 63-67, 1985.
16. Emanuel, P., O'Brien, T., Burans, J., DasGupta, B. R., Valdes, J. J., and Eldefrawi, M., Directing antigen specificity towards botulinum neurotoxin with combinatorial phage display libraries, J. Immunol. Methods, 193 (2), 189-197, 1996.
17. Vinogradov, E., Conlan, J. W., and Perry, M. B., Serological cross-reaction between the lipopolysaccharide O-polysaccharaide antigens of E. coli O157:H7 and strains of Citrobacter freundii and Citrobacter sedlakii, FEMS Microbiol. Lett., 190 (1), 157-161, 2000.
18. Perry, M. B. and Bundle, D. R., Antigenic relationships of the lipopolysaccharides of Escherichia hermannii strains with those of E. coli O157:H7, Brucella melitensis, and Brucella abortus, Infect. Immun., 58 (5), 1391-1395, 1990.
19. Lior, H. and Borczyk, A. A., False positive identifications of Escherichia coli O157, Lancet, 1 (8528), 333, 1987.
20. Bettelheim, K. A., Evangelidis, H., Pearce, J. L., Sowers, E., and Strockbine, N. A., Isolation of a Citrobacter freundii strain which carries the Escherichia coli O157 antigen, J. Clin. Microbiol., 31 (3), 760-761, 1993.
21. Marsden, B. J., Bundle, D. R., and Perry, M. B., Serological and structural relationships between Escherichia coli O:98 and Yersinia enterocolitica O:11,23 and O:11,24 lipopolysaccharide O-antigens, Biochem. Cell Biol., 72 (5-6), 163-168, 1994.
22. Emanuel, P. A., Dang, J., Gebhardt, J. S., Aldrich, J., Garber, E. A., Kulaga, H., Stopa, P., Valdes, J. J., and Dion-Schultz, A., Recombinant antibodies: Anew reagent for biological agent detection, Biosens. Bioelectron., 14 (10-11), 751-759, 2000.
23. Petrenko, V. A. and Smith, G. P., Phages from landscape libraries as substitute antibodies, Protein Eng., 13 (8), 589-592, 2000.
24. Skerra, A., Engineered protein scaffolds for molecular recognition [Review], J. Mol. Recognit., 13 (4), 167-187, 2000.
25. Petrenko, V. A. and Smith, G. P., Vectors and modes of display, In Phage Display in Biotechnology and Drug Discovery, Sidhu, S. S., Ed., Taylor & Francis, Boca Raton, FL, pp. 63-110, 2005.
26. Barbas, C. F. III, Barton, D. R., Scott, J. K., and Silverman, G. J., Phage Display: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 2001.
27. Hoogenboom, H. R., de Bruine, A. P., Hufton, S. E., Hoet, R. M., Arends, J. W., and Roovers, R. C., Antibody phage display technology and its applications, Immunotechnology, 4 (1), 1-20, 1998.
28. Ditzel, H. J., Rescure of a broader range of antibody specificities using an epitope-masking strategy, In Antibody Phage Display, O'Brien, P. M., Ed., Humana Press, Totowa, NJ, pp. 179-186, 2002.
29. Short, M. K., Jeffrey, P. D., Demirjian, A., and Margolies, M. N., A single H: CDR3 residue in the anti-digoxin antibody 26-10 modulates specificity for C16-substituted digoxin analogs, Protein Eng., 14 (4), 287-296, 2001.
30. Barbas, C. F., Hu, D., Dunlop, N., Sawyer, L., Cababa, D., Hendry, R. M., Nara, P. L., and Burton, D. R., In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1to enhance affinity and broaden strain cross-reactivity, Proc. Natl Acad. Sci. U.S.A., 91 (9), 3809-3813, 1994.
31. Chowdhury, P. S., Targeting random mutations to hotspots in antibody variable domains for affinity improvement, In Antibody Phage Display: Methods and Protocols, O'Brien, P.M. and Aitken, R., Eds., Humana Press, Totowa, NJ, pp. 269-286, 2002.
32. Maynard, J. A., Chen, G., Georgiou, G., and Iverson, B. L., In vitro scanning-saturation mutagenesis, Methods Mol. Biol., 182, 149-163, 2002.
33. Pini, A., Spreafico, A., Botti, R., Neri, D., and Neri, P., Hierarchical affinity maturation of a phage library derived antibody for the selective removal of cytomegalovirus from plasma, J. Immunol. Methods, 206 (1-2), 171-182, 1997.
34. Worn, A. and Pluckthun, A., Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability, Biochemistry, 37 (38), 13120-13127, 1998.
35. Marvin, J. S. and Lowman, H. B., Antibody humanization and affinity maturation using phage display, In Phage Display in Biotechnology and Drug Discovery, Sidhu, S. S., Ed., Taylor & Francis, Boca Raton, FL, pp. 493-528, 2005.
36. Jermutus, L., Honegger, A., Schwesinger, F., Hanes, J., and Pluckthun, A., Tailoring in vitro evolution for protein affinity or stability, Proc. Natl Acad. Sci. U.S.A., 98 (1), 75-80, 2001.
37. Reiter, Y., Brinkmann, U., Jung, S. H., Lee, B., Kasprzyk, P. G., King, C. R., and Pastan, I., Improved binding and antitumor activity of a recombinant anti-erbB2 immunotoxin by disulfide stabilization of the Fv fragment, J. Biol. Chem., 269 (28), 18327-18331, 1994.
38. Loeb, T., Isolation of bacteriophage specific for the FC and Hfr mating types of Escherichia coli K12, Science, 131, 932-933, 1960.
39. Hofschneider, P. H., Untersuchungen uber "kleine" E. coli K12 Bacteriophagen M12, M13, und M20, Z. Naturforschg, 18b, 203-205, 1963.
40. Marvin, D. A. and Hoffman-Berling, H., Physical and chemical properties of two new small bacteriophages, Nature (London), 197, 517-518, 1963.
41. Rodi, D. J., Mandava, S., and Makowski, L., Filamentous bacteriophage structure and biology, In Phage Display in Biotechnology and Drug Discovery, Sidhu, S. S., Ed., Taylor & Francis, Boca Raton, FL, pp. 1-61, 2005.
42. Berkowitz, S. A. and Day, L. A., Mass, length, composition and structure of the filamentous bacterial virus fd, J. Mol. Biol., 102 (3), 531-547, 1976.
43. Marvin, D. A., Hale, R. D., Nave, C., and Citterich, M. H., Molecular models and structural comparisons of native and mutant class I filamentous bacteriophages Ff (fd, f1, M13), If1 and IKe, J. Mol. Biol., 235 (1), 260-286, 1994.
44. Smith, G. P., Filamentous fusion phage: Novel expression vectors that display cloned antigens on the virion surface, Science, 228 (4705), 1315-1317, 1985.
45. Il'ichev, A. A., Minenkova, O. O., Tat'kov, S. I., Karpyshev, N. N., Eroshkin, A. M., Petrenko, V. A., and Sandakhchiev, L. S., Production of a viable variant of the M13 phage with a foreign peptide inserted into the basic coat protein, Dokl Akad Nauk SSSR, 307 (2), 481-483, 1989.
46. Petrenko, V. A., Smith, G. P., Gong, X., and Quinn, T., A library of organic landscapes on filamentous phage, Protein Eng., 9 (9), 797-801, 1996.
47. Fellouse, F. A. and Pal, G., Methods for the construction of phage-displayed libraries, In Phage Display in Biotechnology and Drug Discovery, Sidhu, S. S., Ed., Taylor & Francis, Boca Raton, FL, pp. 111-142, 2005.
48. Dennis, M., Selection and screening strategies, In Phage Display in Biotechnology and Drug Discovery, Sidhu, S. S., Ed., Taylor & Francis, Boca Raton, FL, pp. 143-164, 2005.
49. Fellouse, F. A. and Sidhu, S. S., Synthetic antibody libraries, In Phage Display in Biotechnology and Drug Discovery, Sidhu, S. S., Ed., Taylor & Francis, Boca Raton, FL, pp. 709-740, 2005.
50. Berry, J. D. and Popkov, M., Antibody libraries from immunized repertoires, In Phage Display in Biotechnology and Drug Discovery, Sidhu, S. S., Ed., Taylor & Francis, Boca Raton, FL, pp. 529-658, 2005.
51. Dobson, C. L., Minter, R. R., and Hart-Shorrock, C. P., Naive antibody libraries from natural repertoires, In Phage Display in Biotechnology and Drug Discovery, Sidhu, S. S., Ed., Taylor & Francis, Boca Raton, FL, pp. 659-708, 2005.
52. Hoogenboom, H. R., Overview of antibody phage-display technology and its applications, In Antibody Phage Display: Methods and Protocols, O'Brien, P. M. and Aitken, R., Eds., Humana Press, Totowa, NJ, pp. 1-39, 2002.
53. Casey, J. L., Coley, A. M., Tilley, L. M., and Foley, M., Green fluorescent antibodies: Novel in vitro tools, Protein Eng., 13 (6), 445-452, 2000.
54. Kerschbaumer, R. J., Hirschl, S., Kaufmann, A., Ibl, M., Koenig, R., and Himmler, G., Single-chain Fv fusion proteins suitable as coating and detecting reagents in a double antibody sandwich enzyme-linked immunosorbent assay, Anal. Biochem., 249 (2), 219-227, 1997.
55. Morino, K., Katsumi, H., Akahori, Y., Iba, Y., Shinohara, M., Ukai, Y., Kohara, Y., and Kurosawa, Y., Antibody fusions with fluorescent proteins: A versatile reagent for profiling protein expression, J. Immunol. Methods, 257 (1-2), 175-184, 2001.
56. Muller, B. H., Chevrier, D., Boulain, J. C., and Guesdon, J. L., Recombinant single-chain Fv antibody fragment-alkaline phosphatase conjugate for one-step immunodetection in molecular hybridization, J. Immunol. Methods, 227 (1-2), 177-185, 1999.
57. Pearce, L. A., Oddie, G. W., Coia, G., Kortt, A. A., Hudson, P. J., and Lilley, G. G., Linear gene fusions of antibody fragments with streptavidin can be linked to biotin labelled secondary molecules to form bispecific reagents, Biochem. Mol. Biol. Int., 42 (6), 1179-1188, 1997.
58. Chen, G., Dubrawsky, I., Mendez, P., Georgiou, G., and Iverson, B. L., In vitro scanning saturation mutagenesis of all the specificity determining residues in an antibody binding site, Protein Eng., 12 (4), 349-356, 1999.
59. Kortt, A. A., Dolezal, O., Power, B. E., and Hudson, P. J., Dimeric and trimeric antibodies: High avidity scFvs for cancer targeting, Biomol. Eng., 18 (3(Special Issue SI)), 95-108, 2001.
60. Deng, S. J., MacKenzie, C. R., Sadowska, J., Michniewicz, J., Young, N. M., Bundle, D. R., and Narang, S. A., Selection of antibody single-chain variable fragments with improved carbohydrate binding by phage display, J. Biol. Chem., 269 (13), 9533-9538, 1994.
61. Worn, A. and Pluckthun, A., Stability engineering of antibody single-chain Fv fragments, J. Mol. Biol., 305 (5), 989-1010, 2001.
62. Liu, B. and Marks, J. D., Applying phage antibodies to proteomics: Selecting single chain Fv antibodies to antigens blotted on nitrocellulose, Anal. Biochem., 286 (1), 119-128, 2000.
63. Kay, B. K., Winter, J., and McCafferty, J., Phage Display of Peptides and Proteins: A Laboratory Manual, Academic Press, New York, 1996.
64. O'Brien, P. M. and Aitken, R., Antibody Phage Display: Methods and Protocols, 401 ed., Humana Press, Totowa, NJ, 2002.
65. Turnbough, C. L. Jr., Discovery of phage display peptide ligands for species-specific detection of Bacillus spores, J. Microbiol. Methods, 53 (2), 263-271, 2003.
66. Li, B., Tom, J. Y., Oare, D., Yen, R., Fairbrother, W. J., Wells, J. A., and Cunningham, B. C., Minimization of a polypeptide hormone, Science, 270 (5242), 1657-1660, 1995.
67. O'Neil, K. T., Hoess, R. H., Jackson, S. A., Ramachandran, N. S., Mousa, S. A., and DeGrado, W. F., Identification of novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library, Proteins, 14 (4), 509-515, 1992.
68. Gough, K. C., Cockburn, W., and Whitelam, G. C., Selection of phage-display peptides that bind to cucumber mosaic virus coat protein, J. Virol. Methods, 79 (2), 169-180, 1999.
69. Knurr, J., Benedek, O., Heslop, J., Vinson, R., Boydston, J., McAndrew, J., Kearney, J., and Turnbough, C. Jr., Peptide ligands that bind selectively to B. subtilis and closely related species, Appl. Environ. Microbiol., 69, 6841-6847, 2003.
70. Steichen, C., Chen, P., Kearney, J. F., and Turnbough, C. L. Jr., Identification of the immunodominant protein and other proteins of the Bacillus anthracis exosporium, J. Bacteriol., 185 (6), 1903-1910, 2003.
71. Turnbough, C. L. Jr., Discovery of phage display peptide ligands for species-specific detection of Bacillus spores, J. Microbiol. Methods, 53 (2), 263-271, 2003.
72. Stratmann, J., Strommenger, B., Stevenson, K., and Gerlach, G. F., Development of a peptide-mediated capture PCR for detection of Mycobacterium avium subsp. paratuberculosis in milk, J. Clin. Microbiol., 40 (11), 4244-4250, 2002.
73. Grant, I. R., Pope, C. M., O'Riordan, L. M., Ball, H. J., and Rowe, M. T., Improved detection of Mycobacterium avium subsp. paratuberculosis in milk by immunomagnetic PCR, Vet. Microbiol., 77 (3-4), 369-378, 2000.
74. Goldman, E. R., Pazirandeh, M. P., Mauro, J. M., King, K. D., Frey, J. C., and Anderson, G. P., Phage-displayed peptides as biosensor reagents, J. Mol. Recognit., 13, 382-387, 2000.
75. Mammen, M., Choi, S. K., and Whitesides, G. M., Polyvalent interactions in biological systems-implications for design and use of multivalent ligands and inhibitors, Angewandte Chemie. Int. Ed. Eng., 37 (20), 2755-2794, 1998.
76. Zdanovsky, A. G., Karassina, N. V., Simpson, D., and Zdanovskaia, M. V., Peptide phage display library as source for inhibitors of clostridial neurotoxins, J. Protein Chem., 20 (1), 73-80, 2001.
77. Iqbal, S. S., Mayo, M. W., Bruno, J. G., Bronk, B. V., Batt, C. A., and Chambers, J. P., A review of molecular recognition technologies for detection of biological threat agents [Review], Biosens. Bioelectron., 15 (11-12), 549-578, 2000.
78. Sheets, M. D., Amersdorfer, P., Finnern, R., Sargent, P., Lindquist, E., Schier, R., Hemingsen, G., et al., Efficient construction of a large nonimmune phage antibody library: The production of high-affinity human single-chain antibodies to protein antigens, Proc. Natl Acad. Sci. U.S.A., 95 (11), 6157-6162, 1998.
79. Nissim, A., Hoogenboom, H. R., Tomlinson, I. M., Flynn, G., Midgley, C., Lane, D., and Winter, G., Antibody fragments from a'single pot' phage display library as immunochemical reagents, EMBO J., 13 (3), 692-698, 1994.
80. Zhou, B., Wirsching, P., and Janda, K. D., Human antibodies against spores of the genus Bacillus: A model study for detection of and protection against anthrax and the bioterrorist threat, Proc. Natl Acad. Sci. U.S.A., 99 (8), 5241-5246, 2002.
81. Lindquist, E. A., Marks, J. D., Kleba, B. J., and Stephens, R. S., Phage-display antibody detection of Chlamydia trachomatis-associated antigens, Microbiology, 148 (Pt 2), 443-451, 2002.
82. Benhar, I., Eshkenazi, I., Neufeld, T., Opatowsky, J., Shaky, S., and Rishpon, J., Recombinant single chain antibodies in bioelectrochemical sensors, Talanta, 55 (5), 899-907, 2001.
83. Hayhurst, A., Happe, S., Mabry, R., Koch, Z., Iverson, B. L., and Georgiou, G., Isolation and expression of recombinant antibody fragments to the biological warfare pathogen Brucella meli-tensis, J. Immunol. Methods, 276 (1-2), 185-196, 2003.
84. Bundle, D. R., Gidney, M. A., Perry, M. B., Duncan, J. R., and Cherwonogrodzky, J. W., Serological confirmation of Brucella abortus and Yersinia enterocolitica O:9 O-antigens by monoclonal antibodies, Infect. Immun., 46 (2), 389-393, 1984.
85. Samoylova, T. I., Petrenko, V. A., Morrison, N. E., Globa, L. P., Baker, H. J., and Cox, N. R., Phage probes for malignant glial cells, Mol. Cancer Ther., 2 (11), 1129-1137, 2003.
86. Radosevic, K. and van Ewijk, W., Subtractive isolation of single-chain antibodies using tissue fragments, Methods Mol. Biol., 178, 235-243, 2002.
87. Boel, E., Bootsma, H., de Kruif, J., Jansze, M., Klingman, K. L., van Dijk, H., and Logtenberg, T., Phage antibodies obtained by competitive selection on complement-resistant Moraxella (Branha-mella) catarrhalis recognize the high-molecular-weight outer membrane protein, Infect. Immun., 66 (1), 83-88, 1998.
88. Cai, X. H. and Garen, A., Antimelanoma antibodies from melanoma patients immunized with genetically-modified autologous tumor-cells-Selection of specific antibodies from single-chain Fv fusion phage libraries, Proc. Natl Acad. Sci. U.S.A., 92 (14), 6537-6541, 1995.
89. Marks, J. D., Ouwehand, W. H., Bye, J. M., Finnern, R., Gorick, B. D., Voak, D., Thorpe, S. J., Hughes-Jones, N. C., and Winter, G., Human antibody fragments specific for human blood group antigens from a phage display library, BioTechnology, 11 (10), 1145-1149, 1993.
90. de Kruif, J., Boel, E., and Logtenberg, T., Selection and application of human single chain Fv antibody fragments from a semi-synthetic phage antibody display library with designed CDR3 regions, J. Mol. Biol., 248 (1), 97-105, 1995.
91. de Greeff, A., van Alphen, L., and Smith, H. E., Selection of recombinant antibodies specific for pathogenic Streptococcus suis by subtractive phage display, Infect. Immun., 68 (7), 3949-3955, 2000.
92. Chan, S. W., Bye, J. M., Jackson, P., and Allain, J. P., Human recombinant antibodies specific for hepatitis C virus core and envelope E2 peptides from an immune phage display library, J. Gen. Virol., 77 (Pt 10), 2531-2539, 1996.
93. Plaisant, P., Burioni, R., Manzin, A., Solforosi, L., Candela, M., Gabrielli, A., Fadda, G., and Clementi, M., Human monoclonal recombinant Fabs specific for HCV antigens obtained by repertoire cloning in phage display combinatorial vectors, Res. Virol., 148 (2), 165-169, 1997.
94. Sanna, P. P., Williamson, R. A., De Logu, A., Bloom, F. E., and Burton, D. R., Directed selection of recombinant human monoclonal antibodies to herpes simplex virus glycoproteins from phage display libraries, Proc. Natl Acad. Sci. U.S.A., 92 (14), 6439-6443, 1995.
95. Williamson, R. A., Lazzarotto, T., Sanna, P. P., Bastidas, R. B., Dalla Casa, B., Campisi, G., Burioni, R., Landini, M. P., and Burton, D. R., Use of recombinant human antibody fragments for detection of cytomegalovirus antigenemia, J. Clin. Microbiol., 35 (8), 2047-2050, 1997.
96. Muller, B. H., Lafay, F., Demangel, C., Perrin, P., Tordo, N., Flamand, A., Lafaye, P., and Guesdon, J. L., Phage-displayed and soluble mouse scFv fragments neutralize rabies virus, J. Virol. Methods, 67 (2), 221-233, 1997.
97. Schmaljohn, C., Cui, Y., Kerby, S., Pennock, D., and Spik, K., Production and characterization of human monoclonal antibody Fab fragments to vaccinia virus from a phage-display combinatorial library, Virology, 258 (1), 189-200, 1999.
98. Maruyama, T., Parren, P. W., Sanchez, A., Rensink, I., Rodriguez, L. L., Khan, A. S., Peters, C. J., and Burton, D. R., Recombinant human monoclonal antibodies to Ebola virus, J. Infect. Dis., 179 (1), S235-S239, 1999.
99. Kuhne, S. A., Hawes, W. S., La Ragione, R. M., Woodward, M. J., Whitelam, G. C., and Gough, K. C., Isolation of recombinant antibodies against EspA and intimin of Escherichia coli O157:H7, J. Clin. Microbiol., 42 (7), 2966-2976, 2004.
100. Hu, W. G., Thompson, H. G., Alvi, A. Z., Nagata, L. P., Suresh, M. R., and Fulton, R. E., Development of immunofiltration assay by light addressable potentiometric sensor with genetically biotinylated recombinant antibody for rapid identification of Venezuelan equine encephalitis virus, J. Immunol. Methods, 289 (1-2), 27-35, 2004.
101. Hayhurst, A. and Georgiou, G., High-throughput antibody isolation [Review], Curr. Opin. Chem. Biol., 5 (6), 683-689, 2001.
102. Brichta, J., Hnilova, M., and Viskovic, T., Generation of hapten-specific recombinant antibodies: Antibody phage display technology: A review, Vet. Med., 50 (6), 231-252, 2005.
103. Hayhurst, A., Improved expression characteristics of single-chain Fv fragments when fused downstream of the Escherichia coli maltose-binding protein or upstream of a single immunoglobulin-constant domain, Protein Expr., Purif., 18 (1), 1-10, 2000.
104. Strachan, G., Whyte, J. A., Molloy, P. M., Paton, G. I., and Porter, A. J. R., Development of robust, environmental, immunoassay formats for the quantification of pesticides in soil, Environ. Sci. Technol., 34 (8), 1603-1608, 2000.
105. Brichta, J., Vesela, H., and Franek, M., Production of scFv recombinant fragments against 2,4-dichlorophenoxyacetic acid hapten using naive phage library, Veterinarni Medicina, 48 (9), 237-247, 2003.
106. Dooley, H., Grant, S. D., Harris, W. J., Porter, A. J., Shelton, S. A., Graham, B. M., and Strachan, G., Stabilization of antibody fragments in adverse environments immunomethods for detecting a broad range of polychlorinated biphenyls, Biotechnol. Appl. Biochem., 28 (Part 1), 77-83, 1998.
107. Jung, S. and Pluckthun, A., Improving in vivo folding and stability of a single-chain Fv antibody fragment by loop grafting, Protein Eng., 10 (8), 959-966, 1997.
108. McConnell, S. J. and Hoess, R. H., Tendamistat as a scaffold for conformationally constrained phage peptide libraries, J. Mol. Biol., 250 (4), 460-470, 1995.
109. Nord, K., Nord, O., Uhlen, M., Kelley, B., Ljungqvist, C., and Nygren, P. A., Recombinant human factor VIII-specific affinity ligands selected from phage-displayed combinatorial libraries of protein A, Eur. J. Biochem., 268 (15), 4269-4277, 2001.
110. Sollazzo, M., Venturini, S., Lorenzetti, S., Pinola, M., and Martin, F., Engineering minibody-like ligands by design and selection, Chem. Immunol., 65, 1-17, 1997.
111. Bianchi, E., Folgori, A., Wallace, A., Nicotra, M., Acali, A., Phalipon, A., Barbato, G., et al., A conformationally homogeneous combinatorial peptide library, J. Mol. Biol., 247 (2), 154-160, 1995.
112. Dennis, M. S., Herzka, A., and Lazarus, R. A., Potent and selective Kunitz domain inhibitors of plasma kallikrein designed by phage display, J. Biol. Chem., 270 (43), 25411-25417, 1995.
113. Koide, A., Bailey, C. W., Huang, X., and Koide, S., The fibronectin type III domain as a scaffold for novel binding proteins, J. Mol. Biol., 284 (4), 1141-1151, 1998.
114. Ku, J. and Schultz, P. G., Alternate protein frameworks for molecular recognition, Proc. Natl Acad. Sci. U.S.A., 92 (14), 6552-6556, 1995.
115. Legendre, D. and Fastrez, J., Construction and exploitation in model experiments of functional selection of a landscape library expressed from a phagemid, Gene, 290, 203-215, 2002.
116. Martin, F., Toniatti, C., Salvati, A. L., Ciliberto, G., Cortese, R., and Sollazzo, M., Coupling protein design and in vitro selection strategies: Improving specificity and affinity of a designed beta-protein IL-6 antagonist, J. Mol. Biol., 255 (1), 86-97, 1996.
117. Hoess, R. H., Protein design and phage display [Review], Chem. Rev., 101 (10), 3205-3218, 2001.
118. Felici, F., Castagnoli, L., Musacchio, A., Jappelli, R., and Cesareni, G., Selection of antibody ligands from a large library of oligopeptides expressed on a multivalent exposition vector, J. Mol. Biol., 222 (2), 301-310, 1991.
119. Greenwood, J., Willis, A. E., and Perham, R. N., Multiple display of foreign peptides on a filamentous bacteriophage. Peptides from Plasmodium falciparum circumsporozoite protein as antigens, J. Mol. Biol, 220 (4), 821-827, 1991.
120. Petrenko, V. A., Smith, G. P., Mazooji, M. M., and Quinn, T., Alpha-helically constrained phage display library, Protein Eng., 15 (11), 943-950, 2002.
121. Romanov, V. I., Durand, D. B., and Petrenko, V. A., Phage display selection of peptides that affect prostate carcinoma cells attachment and invasion, Prostate, 47 (4), 239-251, 2001.
122. Romanov, V. I., Whyard, T., Adler, H. L., Waltzer, W. C., and Zucker, S., Prostate cancer cell adhesion to bone marrow endothelium: The role of prostate-specific antigen, Cancer Res., 64 (6), 2083-2089, 2004.
123. Samoylova, T. I., Cox, N. R., Morrison, N. E., Globa, L. P., Romanov, V., Baker, H. J., and Petrenko, V. A., Phage matrix for isolation of glioma cell membrane proteins, Biotechniques, 37 (2), 254-260, 2004.
124. Mount, J. D., Samoylova, T. I., Morrison, N. E., Cox, N. R., Baker, H. J., and Petrenko, V. A., Cell targeted phagemid rescued by preselected landscape phage, Gene, 341, 59-65, 2004.
125. Kouzmitcheva, G. A., Petrenko, V. A., and Smith, G. P., Identifying diagnostic peptides for lyme disease through epitope discovery, Clin. Diagn. Lab Immunol., 8 (1), 150-160, 2001.
126. Brigati, J., Williams, D. D., Sorokulova, I. B., Nanduri, V., Chen, I. H., Turnbough, C. L. Jr., and Petrenko, V. A., Diagnostic probes for Bacillus anthracis spores selected from a landscape phage library, Clin. Chem., 50 (10), 1899-1906, 2004.
127. Sorokulova, I. B., Olsen, E. V., Chen, I. H., Fiebor, B., Barbaree, J. M., Vodyanoy, V. J., Chin, B. A., and Petrenko, V. A., Landscape phage probes for Salmonella typhimurium, J. Microbiol. Methods, 63, 55-72, 2005.
128. Olsen, E. V., Sorokulova, I. B., Petrenko, V. A., Chen, I.-H., Barbaree, J. M., and Vodyanoy, V. J., Affinity-selected filamentous bacteriophage as a probe for acoustic wave biodetectors of Salmonella typhimurium, Biosens. Bioelectron, 21, 1434-1442, 2006.
129. Barbas, C. F. III, Burton, D. R., Scott, J. K., and Silverman, G. J., Phage Display: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 2001.
130. Philippa O'Brien, R. A., Antibody Phage Display, Humana Press, Totowa, NJ, 2001.
131. Mandava, S., Makowski, L., Devarapalli, S., Uzubell, J., and Rodi, D. J., RELIC-a bioinformatics server for combinatorial peptide analysis and identification of protein-ligand interaction sites, Proteomics, 4 (5), 1439-1460, 2004.
132. Bishop-Hurley, S. L., Mounter, S. A., Laskey, J., Morris, R. O., Elder, J., Roop, P., Rouse, C., Schmidt, F. J., and English, J. T., Phage-displayed peptides as developmental agonists for Phytophthora capsici zoospores, Appl. Environ. Microbiol., 68 (7), 3315-3320, 2002.
133. Stausbol-Gron, B., Jensen, K. B., Jensen, K. H., Jensen, M. O., and Clark, B. F., De novo identification of cell-type specific antibody-antigen pairs by phage display subtraction. Isolation of a human single chain antibody fragment against human keratin 14, Eur. J. Biochem., 268 (10), 3099-3107, 2001.
134. Van Ewijk, W., de Kruif, J., Germeraad, W. T., Berendes, P., Ropke, C., Platenburg, P. P., and Logtenberg, T., Subtractive isolation of phage-displayed single-chain antibodies to thymic stromal cells by using intact thymic fragments, Proc. Natl Acad. Sci. U.S.A., 94 (8), 3903-3908, 1997.
135. Belizaire, A. K., Tchistiakova, L., St-Pierre, Y., and Alakhov, V., Identification of a murine ICAM-1-specific peptide by subtractive phage library selection on cells, Biochem. Biophys. Res. Commun., 309 (3), 625-630, 2003.
136. Ramanujam, P., Tan, W. S., Nathan, S., and Yusoff, K., Pathotyping of Newcastle disease virus with a filamentous bacteriophage, Biotechniques, 36 (2), 296-300, 2004 see also p. 302.
137. Ramanujam, P., Tan, W. S., Nathan, S., and Yusoff, K., Novel peptides that inhibit the propagation of Newcastle disease virus, Arch. Virol., 147 (5), 981-993, 2002.
138. Yu, J. and Smith, G. P., Affinity maturation of phage-displayed peptide ligands, Methods Enzymol, 267, 3-27, 1996.
139. Goldman, E. R., Pazirandeh, M. P., Mauro, J. M., King, K. D., Frey, J. C., and Anderson, G. P., Phage-displayed peptides as biosensor reagents, J. Mol. Recognit., 13 (6), 382-387, 2000.
140. Knurr, J., Benedek, O., Heslop, J., Vinson, R. B., Boydston, J. A., McAndrew, J., Kearney, J. F., and Turnbough, C. L., Peptide ligands that bind selectively to spores of Bacillus subtilis and closely related species, Appl. Environ. Microbiol., 69 (11), 6841-6847, 2003.
141. Block, T., Miller, R., Korngold, R., and Jungkind, D., A phage-linked immunoadsorbant system for the detection of pathologically relevant antigens, Biotechniques, 7 (7), 756-761, 1989.
142. Lu, X., Weiss, P., and Block, T., A phage with high affinity for hepatitis B surface antigen for the detection of HBsAg, J Virol. Methods, 119 (1), 51-54, 2004.
143. Stratmann, J., Strommenger, B., Stevenson, K., and Gerlach, G. F., Development of a peptide-mediated capture PCR for detection of Mycobacterium avium subsp. paratuberculosis in milk, J. Clin. Microbiol., 40 (11), 4244-4250, 2002.
144. Williams, D. D., Benedek, O., and Tournbough, C. L., Species-specific peptide ligands for the detection of Bacillus anthracis spores, Appl. Environ. Microbiol., 69 (10), 6288-6293, 2003.
145. Zwick, M. B., Labrijn, A. F., Wang, M., Spenlehauer, C., Saphire, E. O., Binley, J. M., Moore, J. P., et al., Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41, J. Virol., 75 (22), 10892-10905, 2001.
146. Emanuel, P. A., Dang, J., Gebhardt, J. S., Aldrich, J., Garber, E. A., Kulaga, H., Stopa, P., Valdes, J. J., and Dion-Schultz, A., Recombinant antibodies: Anew reagent for biological agent detection, Biosens. Bioelectron., 14 (10-11), 751-759, 2000.
147. Emanuel, P., O'Brien, T., Burans, J., DasGupta, B. R., Valdes, J. J., and Eldefrawi, M., Directing antigen specificity towards botulinum neurotoxin with combinatorial phage display libraries, J. Immunol. Methods, 193 (2), 189-197, 1996.
148. Sheets, M. D., Amersdorfer, P., Finnern, R., Sargent, P., Lindquist, E., Schier, R., Hemingsen, G., Wong, C., Gerhart, J. C., Marks, J. D., and Lindquist, E., Efficient construction of a large nonimmune phage antibody library: The production of high-affinity human single-chain antibodies to protein antigens, Proc. Natl Acad. Sci. U.S.A., 95 (11), 6157-6162, 1998.
149. Barbas, C. F., Hu, D., Dunlop, N., Sawyer, L., Cababa, D., Hendry, R. M., Nara, P. L., and Burton, D. R., In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1to enhance affinity and broaden strain cross-reactivity, Proc. Natl Acad. Sci. U.S.A., 91 (9), 3809-3813, 1994.
150. Burton, D. R., Barbas, C. F. III, Persson, M. A., Koenig, S., Chanock, R. M., and Lerner, R. A., A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals, Proc. Natl Acad. Sci. U.S.A., 88 (22), 10134-10137, 1991.
151. Barbas, C. F. III, Crowe, J. E. Jr., Cababa, D., Jones, T. M., Zebedee, S. L., Murphy, B. R., Chanock, R. M., and Burton, D. R., Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity, Proc. Natl Acad. Sci. U.S.A., 89 (21), 10164-10168, 1992.
152. Crowe, J. E., Firestone, C. Y., Crim, R., Beeler, J. A., Coelingh, K. L., Barbas, C. F., Burton, D. R., Chanock, R. M., and Murphy, B. R., Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoprotein, Virology, 252 (2), 373-375, 1998.
153. Bugli, F., Bastidas, R., Burton, D. R., Williamson, R. A., Clementi, M., and Burioni, R., Molecular profile of a human monoclonal antibody Fab fragment specific for Epstein-Barr virus gp350/220 antigen, Hum. Immunol., 62 (4), 362-367, 2001.
154. Plaisant, P., Burioni, R., Manzin, A., Solforosi, L., Candela, M., Gabrielli, A., Fadda, G., and Clementi, M., Human monoclonal recombinant Fabs specific for HCV antigens obtained by repertoire cloning in phage display combinatorial vectors, Res. Virol., 148 (2), 165-169, 1997.
155. Chan, S. W., Bye, J. M., Jackson, P., and Allain, J. P., Human recombinant antibodies specific for hepatitis C virus core and envelope E2 peptides from an immune phage display library, J. Gen. Virol., 77 (Pt 10), 2531-2539, 1996.
156. de Carvalho Nicacio, C., Williamson, R. A., Parren, P. W., Lundkvist, A., Burton, D. R., and Bjorling, E., Neutralizing human Fab fragments against measles virus recovered by phase display, J. Virol., 76 (1), 251-258, 2002.
157. DeLogu, A., Williamson, R. A., Rozenshteyn, R., Ramiro-Ibanez, F., Simpson, C. D., Burton, D. R., and Sanna, P. P., Characterization of a type-common human recombinant monoclonal antibody to herpes simplex virus with high therapeutic potential, J. Clin. Microbiol., 36 (11), 3198-3204, 1998.
158. Sanna, P. P., Williamson, R. A., De Logu, A., Bloom, F. E., and Burton, D. R., Directed selection of recombinant human monoclonal antibodies to herpes simplex virus glycoproteins from phage display libraries, Proc. Natl Acad. Sci. U.S.A., 92 (14), 6439-6443, 1995.
159. Glamann, J., Burton, D. R., Parren, P. W., Ditzel, H. J., Kent, K. A., Arnold, C., Montefiori, D., and Hirsch, V. M., Simian immunodeficiency virus (SIV) envelope-specific Fabs with high-level homologous neutralizing activity: Recovery from a long-term-nonprogressor SIV-infected macaque, J. Virol., 72 (1), 585-592, 1998.
160. Maruyama, T., Rodriguez, L. L., Jahrling, P. B., Sanchez, A., Khan, A. S., Nichol, S. T., Peters, C. J., Parren, P. W., and Burton, D. R., Ebola virus can be effectively neutralized by antibody produced in natural human infection, J. Virol., 73 (7), 6024-6030, 1999.
161. Maruyama, T., Parren, P. W., Sanchez, A., Rensink, I., Rodriguez, L. L., Khan, A. S., Peters, C. J., and Burton, D. R., Recombinant human monoclonal antibodies to Ebola virus, J. Infect. Dis., 179 (1), S235-S239, 1999.
162. Meissner, F., Maruyama, T., Frentsch, M., Hessell, A. J., Rodriguez, L. L., Geisbert, T. W., Jahrling, P. B., Burton, D. R., and Parren, P. W., Detection of antibodies against the four subtypes of Ebola virus in sera from any species using a novel antibody-phage indicator assay, Virology, 300 (2), 236-243, 2002.
163. Muller, B. H., Lafay, F., Demangel, C., Perrin, P., Tordo, N., Flamand, A., Lafaye, P., and Guesdon, J. L., Phage-displayed and soluble mouse scFv fragments neutralize rabies virus, J. Virol. Methods, 67 (2), 221-233, 1997.
164. Griffiths, A. D., Williams, S. C., Hartley, O., Tomlinson, I. M., Waterhouse, P., Crosby, W. L., Kontermann, R. E., et al., Isolation of high affinity human antibodies directly from large synthetic repertoires, EMBO J., 13 (14), 3245-3260, 1994.
165. Saldarelli, P., Keller, H., Dell'Orco, M., Schots, A., Elicio, V., and Minafra, A., Isolation of recombinant antibodies (scFvs) to grapevine virus B, J. Virol. Methods, 124 (1-2), 191-195, 2005.
166. Zebedee, S. L., Barbas, C. F. III, Hom, Y. L., Caothien, R. H., Graff, R., DeGraw, J., Pyati, J., et al., Human combinatorial antibody libraries to hepatitis B surface antigen, Proc. Natl Acad. Sci. U.S.A., 89 (8), 3175-3179, 1992.
167. Williamson, R. A., Lazzarotto, T., Sanna, P. P., Bastidas, R. B., Dalla Casa, B., Campisi, G., Burioni, R., Landini, M. P., and Burton, D. R., Use of recombinant human antibody fragments for detection of cytomegalovirus antigenemia, J. Clin. Microbiol., 35 (8), 2047-2050, 1997.
168. Boel, E., Bootsma, H., de Kruif, J., Jansze, M., Klingman, K. L., van Dijk, H., and Logtenberg, T., Phage antibodies obtained by competitive selection on complement-resistant Moraxella (Branha-mella) catarrhalis recognize the high-molecular-weight outer membrane protein, Infect. Immun., 66 (1), 83-88, 1998.
169. Deng, S. J., MacKenzie, C. R., Hirama, T., Brousseau, R., Lowary, T. L., Young, N. M., Bundle, D. R., and Narang, S. A., Basis for selection of improved carbohydrate-binding single-chain antibodies from synthetic gene libraries, Proc. Natl Acad. Sci. U.S.A., 92 (11), 4992-4996, 1995.
170. Kanitpun, R., Wagner, G. G., and Waghela, S. D., Characterization of recombinant antibodies developed for capturing enterohemorrhagic Escherichia coli O157:H7, Southeast Asian J. Trop. Med. Public Health, 35 (4), 902-912, 2004.
171. Lindquist, E. A., Marks, J. D., Kleba, B. J., and Stephens, R. S., Phage-display antibody detection of Chlamydia trachomatis-associated antigens, Microbiology, 148 (art 2), 443-451, 2002.
172. Zhou, B., Wirsching, P., and Janda, K. D., Human antibodies against spores of the genus Bacillus: A model study for detection of and protection against anthrax and the bioterrorist threat, Proc. Natl Acad. Sci. U.S.A., 99 (8), 5241-5246, 2002.
173. Wan, J. H., Li, Y. Q., Fiebor, B., Chen, I. H., Petrenko, V. A., and Chin, B. A., Detection of Bacillus anthracis spores by landscape phage-based magnetostrictive biosensors, Abstr. Pap. Am. Chem. Soc., 229 (411-ANYL Part) U155-U155, 2005.
174. Lyons, L. B. and Zinder, N. D., The genetic map of the filamentous bacteriophage f1, Virology, 49, 45-60, 1972.
175. Smith, G. P., Phage-Display Vectors and Libraries Based on Filamentous Phage Strain fdtet, http:// www.biosci.missouri.edu/smithgp/PhageDisplayWebsite/PhageDisplayWebsiteIndex.html (accessed September 8, 2006).
176. Khan, A. S., Thompson, R., Cao, C., and Valdes, J. J., Selection and characterization of peptide memitopes binding to ricin, Biotechnol. Lett., 25, 1671-1675, 2003.
177. Tan, W. S., Tan, G. H., Yusoff, K., and Seow, H. F., A phage-displayed cyclic peptide that interacts tightly with the immunodominant region of hepatitis B surface antigen, J. Clin. Virol., 34, 35-41, 2005.
178. Dai, H., Gao, H., Zhao, X., Dai, L., Zhang, X., Xiao, N., Zhao, R., and Hemmingsen, S. M., Construction and characterization of a novel recombinant single-chain variable fragment antibody against white spot syndrome virus from shrimp, J. Immunol. Methods, 279, 267-275, 2003.
179. Yi, G., Qian, J., Wang, Z., and Qi, Y., A phage-displayed peptide can inhibit infection by white spot syndrome virus of shrimp, J. Gen. Virol., 84, 2545-2553, 2003.